Search

Your search keyword '"Shonit Punwani"' showing total 26 results
Start Over Author "Shonit Punwani" Journal journal of urology
26 results on '"Shonit Punwani"'

1. MP44-06 TUMOR CHARACTERISTICS OF MULTIPARAMETRIC MRI-DETECTED AND -UNDETECTED LESIONS IN PATIENTS WITH SUSPECTED RADIORECURRENT PROSTATE CANCER: AN ANALYSIS FROM THE FOCAL RECURRENT ASSESSMENT AND SALVAGE TREATMENT (FORECAST) TRIAL

Author

Alexander Light, Abi Kanthabalan, Menelaos Pavlou, Rumana Omar, Sola Adeleke, Francesco Giganti, Chris Brew-Graves, Amr Emara, Athar Haroon, Arash Latifoltojar, Harbir Sidhu, Alex Freeman, Clement Orczyk, Ashok Nikapota, Tim Dudderidge, Richard G. Hindley, Heather Payne, Anita Mitra, Jamshed Bomanji, Mathias Winkler, Gail Horan, Shonit Punwani, Hashim U. Ahmed, and Taimur T. Shah

Subjects
Urology
Published
2023

2. MP44-02 SYSTEMATIC AND MRI-TARGETED BIOPSY STRATEGIES FOR THE DETECTION OF RADIORECURRENT PROSTATE CANCER: AN ANALYSIS FROM THE FOCAL RECURRENT ASSESSMENT AND SALVAGE TREATMENT (FORECAST) TRIAL

Author

Alexander Light, Abi Kanthabalan, Menelaos Pavlou, Rumana Omar, Sola Adeleke, Francesco Giganti, Chris Brew-Graves, Amr Emara, Athar Haroon, Arash Latifoltojar, Harbir Sidhu, Alex Freeman, Ashok Nikapota, Tim Dudderidge, Richard G. Hindley, Heather Payne, Anita Mitra, Jamshed Bomanji, Mathias Winkler, Gail Horan, Shonit Punwani, Hashim U. Ahmed, and Taimur T. Shah

Subjects
Urology
Published
2023

3. MP73-04 EXTERNAL VALIDATION OF A RISK SCORE PREDICTING FAILURE AFTER SALVAGE FOCAL THERAPY FOR LOCALIZED RADIORECURRENT PROSTATE CANCER: AN ANALYSIS FROM THE FOCAL RECURRENT ASSESSMENT AND SALVAGE TREATMENT (FORECAST) TRIAL

Author

Alexander Light, Max Peters, Abi Kanthabalan, Menelaos Pavlou, Rumana Omar, Sola Adeleke, Francesco Giganti, Chris Brew-Graves, Amr Emara, Athar Haroon, Arash Latifoltojar, Harbir Sidhu, Alex Freeman, Clement Orczyk, Ashok Nikapota, Tim Dudderidge, Richard G. Hindley, Heather Payne, Anita Mitra, Jamshed Bomanji, Mathias Winkler, Gail Horan, Shonit Punwani, Hashim U. Ahmed, and Taimur T. Shah

Subjects
Urology
Published
2023

4. Followup of Men with PI-RADS TM 4 or 5 Abnormality on Prostate Magnetic Resonance Imaging and Nonmalignant Pathological Findings on Initial Targeted Prostate Biopsy. Letter

Author

Francesco Giganti, Mark Emberton, Caroline M. Moore, Alex Freeman, Shonit Punwani, Joseph M. Norris, Nora Pashayan, Vasilis Stavrinides, Clare Allen, and Alex Kirkham

Subjects
PI-RADS, medicine.medical_specialty, medicine.anatomical_structure, Prostate biopsy, medicine.diagnostic_test, Prostate, business.industry, Urology, medicine, Non malignant, Radiology, Abnormality, business
Published
2021

5. MP11-08 NEGATIVE MPMRI RULES OUT EXTRA-PROSTATIC EXTENSION IN PROSTATE CANCER BEFORE RADICAL PROSTATECTOMY

Author

Eoin Dinneen, Ashwin Sridhar, Shaw Greg, Shonit Punwani, John-Patrick Mulligan, Jelena Banjeglav, Dan Heffernan-Ho, Haider Aiman, Veeru Kasivisvanathan, Jacques Grierson, Tom Strange, Alex Freeman, Francesco Giganti, Briggs Tim, Senthil Nathan, and Jamie Lindsay

Subjects
Prostate cancer, medicine.medical_specialty, business.industry, Prostatectomy, Urology, medicine.medical_treatment, Medicine, Extension (predicate logic), business, medicine.disease
Published
2021

6. MP26-07 WHICH PROSTATE CANCERS ARE UNDETECTED BY MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING IN MEN WITH PRIOR PROSTATE BIOPSY? AN ANALYSIS FROM THE PICTURE STUDY

Author

Hashim U. Ahmed, Bloomsbury, Caroline M. Moore, Alex Freeman, Abi Kanthabalan, Neil McCartan, Mark Emberton, Shonit Punwani, Joseph M. Norris, Hayley C. Whitaker, and Lucy A.M. Simmons

Subjects
medicine.medical_specialty, Prostate biopsy, medicine.diagnostic_test, business.industry, Urology, Suspected prostate cancer, equipment and supplies, medicine.anatomical_structure, Prostate, Medicine, Radiology, business, human activities, Multiparametric Magnetic Resonance Imaging
Abstract

INTRODUCTION AND OBJECTIVE:Not all significant cancers are detected by multiparametric magnetic resonance imaging (mpMRI), when risk stratifying for suspected prostate cancer in both biopsy-naive m...

Published
2021

7. Accuracy of Transperineal Targeted Prostate Biopsies, Visual Estimation and Image Fusion in Men Needing Repeat Biopsy in the PICTURE Trial

Author

Charles Jameson, Alex Freeman, Lucy A.M. Simmons, Susan C. Charman, Neil McCartan, Yipeng Hu, Hashim U. Ahmed, Shonit Punwani, Abi Kanthabalan, Mark Emberton, Caroline M. Moore, David J. Hawkes, Dean C. Barratt, Tim Briggs, Jan van der Muelen, and Manit Arya

Subjects
Image-Guided Biopsy, Male, medicine.medical_specialty, Urology, 030232 urology & nephrology, Magnetic Resonance Imaging, Interventional, Perineum, 03 medical and health sciences, Prostate cancer, 0302 clinical medicine, Prostate, Biopsy, Image Processing, Computer-Assisted, medicine, Humans, Prospective Studies, Ultrasonography, Interventional, Multiparametric Magnetic Resonance Imaging, Aged, Image fusion, medicine.diagnostic_test, business.industry, Prostatic Neoplasms, Cancer, Magnetic resonance imaging, Middle Aged, medicine.disease, Prostate-specific antigen, Treatment Outcome, medicine.anatomical_structure, 030220 oncology & carcinogenesis, Feasibility Studies, Biopsy, Large-Core Needle, Radiology, business
Abstract

We evaluated the detection of clinically significant prostate cancer using magnetic resonance imaging targeted biopsies and compared visual estimation to image fusion targeting in patients requiring repeat prostate biopsies.The prospective, ethics committee approved PICTURE trial (ClinicalTrials.gov NCT01492270) enrolled 249 consecutive patients from January 11, 2012 to January 29, 2014. Men underwent multiparametric magnetic resonance imaging and were blinded to the results. All underwent transperineal template prostate mapping biopsies. In 200 men with a lesion this was preceded by visual estimation and image fusion targeted biopsies. As the primary study end point clinically significant prostate cancer was defined as Gleason 4 + 3 or greater and/or any grade of cancer with a length of 6 mm or greater. Other definitions of clinically significant prostate cancer were also evaluated.Mean ± SD patient age was 62.6 ± 7 years, median prostate specific antigen was 7.17 ng/ml (IQR 5.25-10.09), mean primary lesion size was 0.37 ± 1.52 cc with a mean of 4.3 ± 2.3 targeted cores per lesion on visual estimation and image fusion combined, and a mean of 48.7 ± 12.3 transperineal template prostate mapping biopsy cores. Transperineal template prostate mapping biopsies detected 97 clinically significant prostate cancers (48.5%) and 85 insignificant cancers (42.5%). Overall multiparametric magnetic resonance imaging targeted biopsies detected 81 clinically significant prostate cancers (40.5%) and 63 insignificant cancers (31.5%). In the 18 cases (9%) of clinically significant prostate cancer on magnetic resonance imaging targeted biopsies were benign or clinically insignificant on transperineal template prostate mapping biopsy. Clinically significant prostate cancer was detected in 34 cases (17%) on transperineal template prostate mapping biopsy but not on magnetic resonance imaging targeted biopsies and approximately half was present in nontargeted areas. Clinically significant prostate cancer was found on visual estimation and image fusion in 53 (31.3%) and 48 (28.4%) of the 169 patients (McNemar test p = 0.5322). Visual estimation missed 23 clinically significant prostate cancers (13.6%) detected by image fusion. Image fusion missed 18 clinically significant prostate cancers (10.8%) detected by visual estimation.Magnetic resonance imaging targeted biopsies are accurate for detecting clinically significant prostate cancer and reducing the over diagnosis of insignificant cancers. To maximize detection visual estimation as well as image fusion targeted biopsies are required.

Published
2018

8. MP81-19 WHICH PROSTATE CANCERS ARE OVERLOOKED BY MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING? AN ANALYSIS FROM PROMIS

Author

Joseph Norris, Lina Carmona Echeverria, Simon Bott, Louise Brown, Nicholas Burns-Cox, Timothy Dudderidge, Ahmed El-Shater Bosaily, Elena Frangou, Alex Freeman, Maneesh Ghei, Alastair Henderson, Richard Hindley, Richard Kaplan, Alex Kirkham, Robert Oldroyd, Christopher Parker, Raj Persad, Shonit Punwani, Derek Rosario, Iqbal Shergill, Vasilis Stavrinides, Mathias Winkler, Hayley Whitaker, Hashim Ahmed, and Mark Emberton

Subjects
medicine.medical_specialty, Mri imaging, business.industry, Urology, food and beverages, Cancer, medicine.disease, medicine.anatomical_structure, Prostate, Risk stratification, Medicine, Radiology, business, Multiparametric Magnetic Resonance Imaging
Abstract

INTRODUCTION AND OBJECTIVE:All risk stratification strategies in cancer overlook a spectrum of disease. The Prostate MRI Imaging Study (PROMIS) provides a unique opportunity to explore prostate can...

Published
2020

9. MP56-04 MRI INDEX LESIONS IN THE CANCEROUS PROSTATE: HOW DO THEY DIFFER FROM FALSE POSITIVE PHENOTYPES? LESSONS FROM THE PROMIS STUDY

Author

Alex Kirkham, Chris Parker, Maneesh Ghei, Vasilis Stavrinides, Raj Persad, Ahmed El-Shater Bosaily, Joseph M. Norris, Iqbal S. Shergill, Shonit Punwani, Hashim U. Ahmed, Robert Oldroyd, Nicholas Burns-Cox, Hayley C. Whitaker, Richard Kaplan, Simon Bott, Derek J. Rosario, Alex Freeman, Mathias Winkler, Richard Hindley, Lina Carmona, Tim Dudderidge, Mark Emberton, Elena Frangou, Louise Brown, and Alastair Henderson

Subjects
Oncology, medicine.medical_specialty, medicine.anatomical_structure, Index (economics), business.industry, Prostate, Urology, Internal medicine, Medicine, business, Phenotype
Published
2020

10. Re: Does the Visibility of Grade Group 1 Prostate Cancer on Baseline Multiparametric Magnetic Resonance Imaging Impact Clinical Outcomes?

Author

Clare Allen, Rhys Ball, Shonit Punwani, Mark Emberton, Vasilis Stavrinides, Caroline M. Moore, Clement Orczyk, Aiman Haider, Francesco Giganti, Hayley C. Whitaker, Alex Kirkham, and Alex Freeman

Subjects
Male, business.industry, Urology, Visibility (geometry), Prostatic Neoplasms, medicine.disease, Prostate cancer, medicine, Humans, Multiparametric Magnetic Resonance Imaging, Neoplasm Grading, business, Nuclear medicine
Published
2020

11. MP24-19 NEGATIVE PREDICTIVE VALUE OF MULTI-PARAMETRIC MRI IN DETECTION OF CLINICALLY SIGNIFICANT PROSTATE CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS

Author

Roderick C.N. van den Bergh, Hashim U. Ahmed, Freddie C. Hamdy, Fergus V. Gleeson, Alastair D. Lamb, Christof Kastner, James W.F. Catto, Tristan Barrett, Caroline M. Moore, Veerapan Kasivisvanathan, Shonit Punwani, Ruth MacPherson, Altan Omer, Niranjan J. Sathianathen, Declan G. Murphy, and Richard J. Bryant

Subjects
medicine.medical_specialty, Prostate cancer, Multi parametric, business.industry, Urology, Meta-analysis, medicine, Medical physics, medicine.disease, business, Predictive value, Reference standards, Systematic search
Abstract

INTRODUCTION AND OBJECTIVES:Pre-biopsy multi-parametric MRI (mpMRI) is increasingly used in prostate cancer diagnosis. The reported negative predictive value (NPV) of mpMRI is used by some clinicians to aid decision making about whether or not to proceed to biopsy. Our contemporary systematic review update of the NPV of mpMRI for clinically significant prostate cancer reflects the latest literature on optimal mpMRI techniques and scoring systems, and aims to provide the latest NPV of mpMRI in this setting.METHODS:We conducted a systematic literature search and included studies from 2016-2018 which assessed the NPV of mpMRI for clinically significant prostate cancer, using biopsy or clinical follow-up as the reference standard. To ensure that studies included in this analysis reflect contemporary practice, we only included studies in which mpMRIs were interpreted according to the PIRADS or similar institutional Likert grading system. We define a negative mpMRI as either (1) PIRADS/Likert 1-2 or (2) PIRADS/...

Published
2019

14. PD50-02 NATURAL HISTORY OF PROSTATE CANCER ON ACTIVE SURVEILLANCE: STRATIFICATION BY MRI USING THE PRECISE RECOMMENDATIONS IN A UK COHORT OVER 11 YEARS

Author

Valeria Panebianco, Alex Freeman, Alex Kirkham, Francesco Giganti, Shonit Punwani, Mark Emberton, Adam Retter, Charles Jameson, Vasilis Stavrinides, Clare Allen, Clement Orczyk, Armando Stabile, and Carolines M Moore

Subjects
Oncology, Natural history, Prostate cancer, medicine.medical_specialty, business.industry, Urology, Internal medicine, Cohort, medicine, Stratification (water), medicine.disease, business
Published
2019

15. MP77-15 A MULTI-CENTRE RANDOMISED CONTROLLED TRIAL ASSESSING WHETHER MRI-TARGETED BIOPSY IS NON-INFERIOR TO STANDARD TRANS-RECTAL ULTRASOUND GUIDED BIOPSY FOR THE DIAGNOSIS OF CLINICALLY SIGNIFICANT PROSTATE CANCER IN MEN WITHOUT PRIOR BIOPSY - THE PRECISION STUDY: PROSTATE EVALUATION FOR CLINICALLY IMPORTANT DISEASE, SAMPLING USING IMAGE-GUIDANCE OR NOT? (NCT02380027)

Author

Samir S. Taneja, Geert Villeirs, Silvan Boxler, Arnauld Villers, Boris Hadaschik, Sebastien Crouzet, Francesco Giganti, Jaspal Virdi, Veeru Kasivisvanathan, Chris Brew-Graves, Valeria Panebianco, Lars Budäus, Antti Rannikko, Markku H. Vaarala, Caroline M. Moore, Grégoire Robert, Steve Morris, Maneesh Ghei, Alex Freeman, Alberto Briganti, Norman R. Williams, Mark Emberton, Scott E. Eggener, Wulphert Venderink, Paras B. Singh, Yemisi Takwoingi, Richard Hindley, Alain Ruffion, Marcelo Borghi, Franck Bladou, Jim C. Hu, Lance Mynderse, Daniel Margolis, Clare Allen, Shonit Punwani, Giles O. Hellawell, Inderbir S. Gill, Monique J. Roobol, Peter A. Pinto, and Laurence Klotz

Subjects
medicine.medical_specialty, medicine.diagnostic_test, business.industry, Urology, Disease, medicine.disease, Targeted biopsy, law.invention, Prostate cancer, medicine.anatomical_structure, Randomized controlled trial, law, Prostate, Biopsy, medicine, Sampling (medicine), Radiology, Multi centre, business
Published
2018

16. PD37-02 A PROSPECTIVE MULTICENTER STUDY COMPARING MULTI-PARAMETRIC MAGNETIC RESONANCE IMAGING (MP-MRI), F-18 FLUORO-METHYL-CHOLINE (FCH) AND GA-68 HBED-CC- (PSMA) POSITRON EMISSION TOMOGRAPHY IN PATIENTS BEING CONSIDERED FOR SALVAGE RADIATION THERAPY FOR BIOCHEMICAL FAILURE AFTER RADICAL PROSTATECTOMY

Author

Andrew Weickhardt, Glenn Bauman, Louise Emmett, Ur Metser, Frédéric Pouliot, Sue Chua, Shonit Punwani, Andrew M. Scott, Ian D. Davis, and Rod Hicks

Subjects
Multi parametric, medicine.diagnostic_test, business.industry, Prostatectomy, Urology, medicine.medical_treatment, 030232 urology & nephrology, Magnetic resonance imaging, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Salvage radiation, chemistry, Multicenter study, Positron emission tomography, 030220 oncology & carcinogenesis, medicine, Choline, In patient, business, Nuclear medicine
Published
2018

17. PD43-06 A MULTIVARIATE LOGISTIC REGRESSION INVESTIGATING WHICH FACTORS INFLUENCE DETECTION OF CLINICALLY SIGNIFICANT CANCER BY MRI-TARGETED PROSTATE BIOPSY

Author

Jan van der Meulen, Henrietta Mair, Hashim U. Ahmed, Ross Warner, Sara Renshaw, Alistair Grey, Esmee van der Saar, Osayuki Nehikhare, Mark Emberton, Susan A. Charman, Shonit Punwani, Caroline M. Moore, and Veeru Kasivisvanathan

Subjects
Oncology, medicine.medical_specialty, Prostate biopsy, medicine.diagnostic_test, business.industry, Urology, Internal medicine, medicine, Cancer, Logistic regression, business, medicine.disease
Published
2017

18. MP70-02 CORRELATION OF MPMRI CONTOURS WITH 3-DIMENSIONAL 5MM TRANSPERINEAL PROSTATE MAPPING BIOPSY WITHIN THE PROMIS TRIAL PILOT: WHAT MARGINS ARE REQUIRED?

Author

Dean C. Barratt, Esther Bonmati, Richard Kaplan, Eli Gibson, Hashim U. Ahmed, Mark Emberton, Yipeng Hu, Clement Orczyk, Alex Kirkham, Yolana Coraco-Moraes, Shonit Punwani, Ahmed El-Shater Bosaily, Louise Brown, and Katie Ward

Subjects
medicine.medical_specialty, medicine.anatomical_structure, medicine.diagnostic_test, Prostate, business.industry, Urology, Biopsy, medicine, Radiology, business
Published
2017

19. MP38-07 SHOULD WE AIM FOR THE CENTRE OF AN MRI PROSTATE LESION? CORRELATION BETWEEN MPMRI AND 3-DIMENSIONAL 5MM TRANSPERINEAL PROSTATE MAPPING BIOPSIES FROM THE PROMIS TRIAL

Author

Yipeng Hu, Dean C. Barratt, Esther Bonmati, Hashim U. Ahmed, Ahmed El-Shater Bosaily, Mark Emberton, Louise Brown, Shonit Punwani, Katie Ward, Alex Kirkham, Yolana Coraco-Moraes, Eli Gibson, Clement Orczyk, and Richard Kaplan

Subjects
Lesion, medicine.medical_specialty, medicine.anatomical_structure, Prostate, business.industry, Urology, medicine, Radiology, medicine.symptom, business
Published
2017

20. MP51-12 A TRAINING COURSE FOR THE UROLOGIST IMPROVES THEIR ABILITY TO INTERPRET CLINICALLY SIGNIFICANT PROSTATE CANCER ON MULTIPARAMETRIC MRI

Author

Jan van der Meulen, Alex Kirkham, Mark Emberton, Shonit Punwani, Veeru Kasivisvanathan, Vasilis Stavrinides, Clare Allen, Lina Carmona, Susan A. Charman, and Caroline M. Moore

Subjects
medicine.medical_specialty, Prostate cancer, business.industry, Urology, Training course, medicine, Multiparametric MRI, Radiology, medicine.disease, business
Published
2017

21. MP53-03 TRANSPERINEAL MRI VISUALLY-TARGETED PROSTATE BIOPSIES COMPARED TO TEMPLATE MAPPING BIOPSY IN 534 MEN REQUIRING FURTHER RISK STRATIFICATION

Author

Mark Emberton, Tom Hartingon, Navin Ramachandran, Alex Freeman, Hashim U. Ahmed, Manit Arya, Clare Allen, Giorgia Trevisan, Caroline M. Moore, Shonit Punwani, Alistair Grey, and Miles Walkden

Subjects
medicine.medical_specialty, medicine.anatomical_structure, medicine.diagnostic_test, business.industry, Prostate, Urology, Biopsy, Risk stratification, Medicine, Radiology, business
Published
2016

22. MP83-01 TRANSPERINEAL MRI-TARGETED BIOPSY VERSUS TRANSPERINEAL TEMPLATE PROSTATE MAPPING BIOPSY IN THE DETECTION OF LOCALISED RADIO-RECURRENT PROSTATE CANCER

Author

Alex Freeman, Mark Emberton, Hashim U. Ahmed, Mohammed Abl-Azzeez, Manit Arya, Clare Allen, Abi Kanthabalan, Alex Kirkham, and Shonit Punwani

Subjects
medicine.medical_specialty, medicine.diagnostic_test, business.industry, Urology, medicine.disease, Targeted biopsy, Prostate cancer, medicine.anatomical_structure, Prostate, Biopsy, medicine, Recurrent prostate cancer, Radiology, business
Published
2015

24. MP67-11 PROSTATE IMAGING (MULTI-PARAMETRIC MRI AND PROSTATE HISTOSCANNING™) COMPARED TO TRANSPERINEAL ULTRASOUND GUIDED BIOPSY FOR SIGNIFICANT PROSTATE CANCER RISK EVALUATION- THE PICTURE STUDY

Author

Alex Freeman, Hashim U. Ahmed, Susan C. Charman, Jan Van der Mullen, Lucy A.M. Simmons, Dean Barrett, Mark Emberton, Yipeng Hu, Shonit Punwani, Caroline M. Moore, and Ana Kanthbalan

Subjects
Prostate cancer risk, medicine.medical_specialty, medicine.anatomical_structure, Multi parametric, medicine.diagnostic_test, business.industry, Prostate, Urology, Biopsy, Medicine, Radiology, Transperineal ultrasound, business
Published
2014

25. Re: Multiparametric Magnetic Resonance Imaging Guided Diagnostic Biopsy Detects Significant Prostate Cancer and could Reduce Unnecessary Biopsies and Over Detection: A Prospective Study

Author

Manit Arya, Mark Emberton, Hashim U. Ahmed, A. Freeman, Shonit Punwani, A. El-Shater Bosaily, and Alex Kirkham

Subjects
Male, Pathology, medicine.medical_specialty, medicine.diagnostic_test, business.industry, Urology, Prostate, Prostatic Neoplasms, Unnecessary Procedures, medicine.disease, Magnetic Resonance Imaging, Prostate cancer, Biopsy, medicine, Humans, Radiology, Prospective cohort study, business, Multiparametric Magnetic Resonance Imaging
Published
2015

26. 1251 THE START CONSORTIUM RECOMMENDATIONS FOR THE REPORTING OF MRI–TARGETED PROSTATE BIOPSIES

Author

Osamu Ukimura, Jurgen J. Fütterer, Yuji Watanabe, Caroline M. Moore, Jonathan Melamed, Veeru Kasivisvanathan, Baris Turkbey, Suzanne L. Palmer, Aytekin Oto, Arnauld Villers, Laurence Klotz, Mark Emberton, Phillipe Puech, Shonit Punwani, Daniel Margolis, Jan van der Meulen, Peter A. Pinto, Robert L. Grubb, Andrew B. Rosenkrantz, Leonard S. Marks, Boris Hadashick, Richard Simon, Scott E. Eggener, Ivo G. Schoots, Inderbir S. Gill, and Samir S. Taneja

Subjects
Kingdom, Pathology, medicine.medical_specialty, business.industry, Urology, Medicine, business, Humanities
Abstract

Caroline Moore*, Veeru Kasivisvanathan, London, United Kingdom; Scott Eggener, Chicago, IL; Mark Emberton, London, United Kingdom; Jurgen Futterer, Nijemgen, Netherlands; Inderbir Gill, Los Angeles, CA; Robert Grubb, Washington, DC; Boris Hadashick, Heidelberg, Germany; Laurence Klotz, Toronto, Canada; Daniel Margolis, Leonard Marks, Los Angeles, CA; Jonathan Melamed, New York, NY; Aytekin Oto, Chicago, IL; Suzanne Palmer, Los Angeles, CA; Peter Pinto, Bethesda, MD; Phillipe Puech, Lille, France; Shonit Punwani, London, United Kingdom; Andrew Rosenkrantz, New York, NY; Ivo Schoots, Rotterdam, Netherlands; Richard Simon, Bethesda, MD; Samir Taneja, New York, NY; Baris Turkbey, Bethesda, MD; Osamu Ukimura, Los Angeles, CA; Jan van der Meulen, London, United Kingdom; Arnauld Villers, Lille, France; Yuji Watanabe, Kurashiki, Japan

Published
2013

Catalog

Books, media, physical & digital resources
See catalog results